
Dr. Dunphy's research interests include conducting clinical research by designing therapies using new technologies and new drugs for patients with Lung malignancies and Head and Neck cancer. The goal is to develop novel therapies that are simple to administer as an outpatient and to pursue organ preservation.
Education and Training
- Fellow In Oncology, Medicine, University of Texas Medical School at Houston, 1986 - 1987
- Fellow In Hematology Oncology, Medicine, Louisiana State University at Shreveport, 1983 - 1985
- Medical Resident, Medicine, Louisiana State University at Shreveport, 1980 - 1983
- Intern In Surgery, Surgery, Charity Hospital, 1979 - 1980
- M.D., Louisiana State University at Shreveport, 1979
Grants
- Genentech GO29537
- A phase III, open-label, randomized study of AZD9291 versus platinum based doubl chemotherapy for patients with locally
- A lead-in phase II multicentre, randomised, double-blind study comparing AZD1775 plus Docetaxel and placebo plus Docetax
- A phase II, Open-label, single-arm study to assess the safety and efficacy of AZD9291 in patients with locally advanced/
- An open label, randomized phase 3 clincal trial of Nivolumab vs therapy of investigator's choice in recurrent or metasti